Therma Bright Inc is experiencing a significant surge in its stock price, reflecting investor optimism.
Therma Bright Inc (THRM.V) is rising today, with its stock price climbing by an impressive 22.22%. This surge shows a growing interest in the company's products, especially in the U.S. market.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Therma Bright Inc
THRM.V
THRM.V
Therma Bright Inc
WealthAwesomeMarket cap
$3.06M
52W high
$0.12
52W low
$0.04
1W change
+0.00%
Beta
1.11
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on THRM's historical volatility
30-Day Vol
114.7%
Annualized
90-Day Vol
96.0%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.06
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.04 – C$0.08 |
| 60 trading days | C$0.06 | C$0.03 – C$0.10 |
| 90 trading days | C$0.06 | C$0.03 – C$0.11 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should keep an eye on the momentum in Therma Bright's stock, as increased demand for its Venowave device could signal potential for further growth.
Stock Rises 22.22% Today
The stock's current price of CA$0.06 reflects a market cap of approximately CA$3.36 million, highlighting the company's small size in the competitive health tech landscape.
Bull case
The recent announcement of expanded U.S. orders for the Venowave device suggests strong demand in the healthcare sector, which could lead to sustained revenue growth for Therma Bright.
Bear case
Despite today's gains, investors should be cautious. The company has yet to show consistent profitability, and its reliance on a single product could pose risks.
Surge Driven by U.S. Demand
Therma Bright's stock is rising today mainly due to the announcement of expanded orders for its Venowave device from U.S. customers. This increase in demand highlights the product's growing acceptance in the healthcare market, particularly in vascular health.
Market Reactions and Future Outlook
The market's positive reaction to Therma Bright's recent developments indicates a shift in investor sentiment. However, with a market cap of just over CA$3 million, the company remains vulnerable to fluctuations. Investors should watch how these developments translate into long-term growth. For more insights, check out our detailed analysis on Therma Bright Inc.
Advertisement
